Identification and initial experimental assessment of DCLK3 as a potential sarcopenia biomarker: A multi-omics and machine learning approach
Open Access
- 7 May 2026
- journal article
- Published by Elsevier in Immunobiology
- Vol. 231 (3) , 153186
Abstract
No abstract availableKeywords
Funding Information
- Special Project of Central Government for Local Science and Technology Development of Hubei Province (2023ZYD0288)
This publication has 49 references indexed in Scilit:
- Identifying semaphorin 3C as a biomarker for sarcopenia and coronary artery disease via bioinformatics and machine learningArchives of Gerontology and Geriatrics, 2025
- Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysisAgeing Research Reviews, 2022
- Functional contribution of DCLKs in sea urchin developmentDevelopmental Dynamics, 2021
- Pericytes in Skeletal Muscle2019
- The relationship between sarcopenia and fragility fracture—a systematic reviewOsteoporosis International, 2019
- Stages of sarcopenia and the incidence of falls in older women: A prospective studyArchives of Gerontology and Geriatrics, 2018
- Sarcopenia – The search for emerging biomarkersAgeing Research Reviews, 2015
- Finding good biomarkers for sarcopeniaJournal of Cachexia, Sarcopenia and Muscle, 2012
- Inflammatory Markers and Loss of Muscle Mass (Sarcopenia) and StrengthThe American Journal of Medicine, 2006
- Presence of a 1,25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblastsBiochemical and Biophysical Research Communications, 1985